Evidence for Direct Inhibition of MHC-Restricted Antigen Processing by Dexamethasone

Sun-A Im1, Turmunkh Gerelchuluun2, Chong-Kil Lee1

  • 1College of Pharmacy, Chungbuk National University, Cheongju 362-763, Korea.

Immune Network
|January 1, 2015
PubMed

Insights

Dexamethasone (Dex) inhibits antigen processing in macrophages, impacting T cell responses. This steroid treatment blocks the presentation of phagocytosed antigens, particularly in immature cells.

Area of Science:

  • Immunology
  • Cell Biology
  • Pharmacology

Background:

  • Dexamethasone (Dex) is known to affect dendritic cell (DC) functions.
  • Understanding Dex's impact on antigen processing in other immune cells is crucial.

Purpose of the Study:

  • To investigate the direct effects of Dexamethasone on MHC-restricted antigen processing in macrophages.
  • To determine if Dex interferes with the intracellular processing of phagocytosed antigens.

Main Methods:

  • Macrophages were incubated with microencapsulated ovalbumin (OVA) and varying concentrations of Dex.
  • OVA-specific CD8 and CD4 T cell responses were used to assess antigen presentation efficacy.
  • Presentation of exogenously added OVA peptide SIINFEKL was also evaluated.

Main Results:

  • Dex inhibited both MHC class I and class II restricted presentation of OVA to T cells.
  • The inhibitory effect was more pronounced in immature macrophages compared to mature ones.
  • Dex did not block the presentation of exogenous SIINFEKL peptide and did not affect phagocytosis or MHC/co-stimulatory molecule expression.

Conclusions:

  • Dexamethasone directly inhibits intracellular processing of phagocytosed antigens in macrophages.
  • This inhibition affects antigen presentation to both CD4+ and CD8+ T cells.
  • The findings highlight Dex's role in modulating macrophage antigen processing pathways.

Related Concept Videos

Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
3.2K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.9K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
297
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.1K